Concepedia
Statistics
Publications
16
Citations
756
H-Index
13
Active since
2007
Affiliations
Genentech(Current)
PDL BioPharma (United States)
Research & Diagnostic Antibodies (United States)
Cell Culture Company (United States)
Whitney Shatz-Binder is an author at Genentech specializing in pharmacy, biochemistry, and antibody engineering.
Publications per year
2007–2024
Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
Christoph Spiess, Mark Merchant, Arthur Huang et al. · Nature Biotechnology · 2013 · 200 citations
Pharmacy, Immunology, Molecular Biology +16
Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity
Whitney Shatz-Binder, Shan Chung, Bing Li et al. · mAbs · 2013 · 86 citations · Full text
Pharmacy, Immunology, Molecular Biology +17
Development of a Human IgG4 Bispecific Antibody for Dual Targeting of Interleukin-4 (IL-4) and Interleukin-13 (IL-13) Cytokines
Christoph Spiess, Jack Bevers, Janet Jackman et al. · Journal of Biological Chemistry · 2013 · 72 citations · Full text
Pharmacy, Biotechnology, Immunology +17
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab
Whitney Shatz-Binder, Philip E. Hass, Mary Mathieu et al. · Molecular Pharmaceutics · 2016 · 72 citations
Pharmacy, Ophthalmology, Pharmacokinetics +17
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular Therapeutics
Kapil Gadkar, Cinthia V. Pastuskovas, Jennifer E. Le Couter et al. · Investigative Ophthalmology & Visual Science · 2015 · 68 citations
Pharmacy, Ophthalmology, Pharmacology +17
1–5 of 16